Science
Pharmalittle: Drug launch prices rose, AZ and Oracle team up on AI The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.
The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.
Dr. Kai NakamuraChief Science CorrespondentPublished Oct 20, 2026 at 9:04 PM EDT · 1 min read
Pharmalittle: Drug launch prices rose, AZ and Oracle team up on AI The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025. The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.